PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8959132

[Recent progress in radiotherapy].

P Bey·P Aletti·M Lapeyre·C Marchal·D Peiffert
View original source ↗Export metadata ↓

Abstract

UNLABELLED: Radiation therapy has considerably evolved in 1 century. After the revolution due to cobalt in the beginning of the sixties, we are now entering the 2nd revolution in three fields in external radiotherapy. METHODOLOGY: the development of quality assurance programmes gives the guarantee that the treatment is done as it is prescribed. Technology: recent developments allow conformal radiation therapy which permits to increase the dose without increasing side effects. Biology: the implementation of predictive assays will permit to choose the best modality of treatment for each patient. In brachytherapy, the use of high dose rate radioactive sources increases indications in locations not yet accessible. Pulse dose rate brachytherapy increases radio-protection and will make optimization possible in complex volumes. In the future, indications of curative radiotherapy will probably increase in regard to earlier diagnosis of many cancers and to increase of efficacy of general treatments on metastatic disease.

Explore related subjects

BrachytherapyDose-Response Relationship, RadiationHumansQuality Assurance, Health CareRadiotherapyRadiotherapy DosageEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Bey, P Aletti, M Lapeyre, C Marchal, D Peiffert. 1996. [Recent progress in radiotherapy].. https://doi.org/10.1016/0248-8663(96)83705-2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Interstitial radiation for recurrent cervix or endometrial cancer in the suburethral region.

Recurrent tumors in the suburethral area are uncommon, but potentially morbid lesions. Brachytherapy, with or without external beam irradiation, was used to treat 10 consecutive women with lesions ranging from 1-6 cm in the suburethral area. All women achieved local control, with one woman developing a serious complication. Four of the 10 women remain alive without evidence of disease. A high rate of distant metastasis in those women who have recurred despite previous adjuvant pelvic radiation following hysterectomy for endometrial cancer should prompt the investigation of effective systemic chemotherapeutic agents.

Brachytherapy↗
PubMed1998

Monte Carlo-based dose-rate tables for the Amersham CDCS.J and 3M model 6500 137Cs tubes.

PURPOSE: (1) To present reference-quality dose-rate distributions for the Amersham CDCS.J-type 137Cs intracavitary source (hitherto unavailable in the literature) and updated tables for the 3M model 6500/6D6C source. (2) To assess the accuracy of the widely used 1D pathlength (Sievert integral) algorithm for lightly filtered 137Cs tube sources. METHODS AND MATERIALS: A Monte Carlo photon-transport code is used to calculate the dose-rate distributions about the 3M source and the CDCS.J source based on radiographic examination of the sources and the vendors' specifications. Dose-rate distributions are provided in the form of Cartesian "away-and-along" lookup tables. Using a general form of the Sievert integral, calculated dose-rate distributions were compared to the Monte Carlo benchmark calculations treating the filtration coefficients as best-fit parameters as well as approximating them by linear energy absorption coefficients. In addition, the errors introduced by approximating the active source core by uniform cylinders or line sources was evaluated. RESULTS: The Model CDCS.J dose distribution differs from that of the 3M model 6500 source by -5.9% to +14.4% (root-mean-square [RMS] average: 2.6%). The RMS accuracy of the Sievert algorithm is 2.4% to 2.8% (error range of -1.4% to 7.6%) when filtration coefficients for steel and ceramic media are approximated by linear energy absorption coefficients. If the filtration coefficients are treated as parameters of best fit, selected to minimize the discrepancies between 1D pathlength and Monte Carlo calculations, the RMS error is reduced to 0.8% (error range of -1.8% to 4.1%). The optimal values of stainless steel and low-density ceramic or glass filtration coefficients are approximately independent of the source geometry. CONCLUSIONS: The widely used Sievert integral algorithm accurately characterizes the dose distribution around stainless-steel clad low-density matrix 137Cs sources, particularly if design-independent best-fit values of the filtration coefficients are used. Although both families of source designs studied produce similar dose distributions, source-design specific dose distributions should be used for clinical treatment planning and dose-algorithm validation.

Brachytherapy↗
PubMed1998

Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy.

PURPOSE: To investigate the feasibility and utility of performing centralized postimplant analysis for transperineal interstitial permanent prostate brachytherapy (TIPPB) by conducting a pilot study that compares the results obtained from 125I implants conducted at five different institutions. METHODS AND MATERIALS: Dose-volume histogram (DVH) analysis was performed on 10 postimplant CT scans from each of five institutions. This analysis included the total implanted activity of 125I, ultrasound, and CT volumes of the prostate, target-volume ratios, dose homogeneity quantifiers, prostate dose coverage indices, and rectal doses. As a result of the uncertainty associated with the delineation of the prostatic boundaries on a CT scan, the contours were redrawn by a single, study center physician, and a repeat DVH analysis was performed. This provided the basis for comparison between institutions in terms of implant technique and quality. RESULTS: By comparing total activity to preimplant ultrasound volume we clearly demonstrated that differences exist in implant technique among these five institutions. The difficulty associated with determining glandular boundaries on CT scans was apparent, based upon the variability in prostate volumes drawn by the various investigators compared to those drawn by the study center physician. This made no difference, of course, in the TVR or homogeneity quantifiers that are independent of target location. Furthermore, this variability made surprisingly little difference in terms of dose coverage of the prostate gland. Rectal doses varied between institutions according to the various implant techniques. CONCLUSIONS: Centralized, outcome-based evaluation of transperineal interstitial permanent prostate brachytherapy is viable and appropriate. Such an approach could be reasonably used in the conduct of multiinstitutional trials used to study the efficacy of the procedure.

Brachytherapy↗